Ci Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Ci Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Ci Capital.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Topaz Energy Corp. stock logo
TPZ
Topaz Energy
C$22.36
-0.2%
1/17/2023Target Lowered byCi Capital-C$29.00 -> C$27.00N/AView details for Ci Capital rating of Topaz Energy (TSE:TPZ) on 1/17/2023
Freehold Royalties Ltd. stock logo
FRU
Freehold Royalties
C$14.18
-0.8%
8/12/2021Target Raised byCi Capital-C$12.50N/AView details for Ci Capital rating of Freehold Royalties (TSE:FRU) on 8/12/2021
InflaRx stock logo
IFRX
InflaRx
$1.37
+1.5%
9/14/2020Reiterated byCi Capital-Hold$7.00HighView details for Ci Capital rating of InflaRx (NASDAQ:IFRX) on 9/14/2020
Calliditas Therapeutics AB (publ) stock logo
CALT
Calliditas Therapeutics AB (publ)
$18.27
-2.3%
8/18/2020Reiterated byCi Capital-Buy$44.00LowView details for Ci Capital rating of Calliditas Therapeutics AB (publ) (NASDAQ:CALT) on 8/18/2020
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$17.30
-0.2%
8/11/2020Reiterated byCi Capital-Buy$22.00LowView details for Ci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 8/11/2020
VYNE Therapeutics Inc. stock logo
VYNE
VYNE Therapeutics
$2.35
+4.4%
8/6/2020Reiterated byCi Capital-Buy$504.00LowView details for Ci Capital rating of VYNE Therapeutics (NASDAQ:VYNE) on 8/6/2020
Immunovant, Inc. stock logo
IMVT
Immunovant
$28.74
+1.8%
8/5/2020Reiterated byCi Capital-Buy$32.00MediumView details for Ci Capital rating of Immunovant (NASDAQ:IMVT) on 8/5/2020
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$23.87
+4.7%
8/5/2020Reiterated byCi Capital-Buy$35.00HighView details for Ci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/5/2020
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
$3.37
+3.7%
7/5/2020Reiterated byCi Capital-Buy$180.00HighView details for Ci Capital rating of MEI Pharma (NASDAQ:MEIP) on 7/5/2020
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
$3.37
+3.7%
6/22/2020Reiterated byCi Capital-Buy$180.00HighView details for Ci Capital rating of MEI Pharma (NASDAQ:MEIP) on 6/22/2020
InflaRx stock logo
IFRX
InflaRx
$1.37
+1.5%
5/28/2020Reiterated byCi Capital-Hold$7.00MediumView details for Ci Capital rating of InflaRx (NASDAQ:IFRX) on 5/28/2020
AGF Management Limited stock logo
AGF.B
AGF Management
C$7.84
-0.1%
3/28/2019Target Lowered byCi Capital-C$6.50 -> C$6.00N/AView details for Ci Capital rating of AGF Management (TSE:AGF.B) on 3/28/2019
Cascades Inc. stock logo
CAS
Cascades
C$9.29
7/4/2017Target Raised byCi Capital-C$17.00 -> C$19.00N/AView details for Ci Capital rating of Cascades (TSE:CAS) on 7/4/2017
Cascades Inc. stock logo
CAS
Cascades
C$9.29
4/7/2017Target Raised byCi Capital-C$17.00 -> C$19.00N/AView details for Ci Capital rating of Cascades (TSE:CAS) on 4/7/2017
Centamin plc stock logo
CEY
Centamin
GBX 124.08
-1.5%
3/15/2016Reiterated byCi Capital-OverweightN/AView details for Ci Capital rating of Centamin (LON:CEY) on 3/15/2016
WSP Global Inc. stock logo
WSP
WSP Global
C$210.49
+0.4%
4/1/2014Target Raised byCi Capital-C$38.00 -> C$40.00N/AView details for Ci Capital rating of WSP Global (TSE:WSP) on 4/1/2014
Quebecor, Inc. stock logo
QBR.B
Quebecor
C$28.58
+0.1%
8/9/2013Target Raised byCi Capital-C$47.00 -> C$51.00N/AView details for Ci Capital rating of Quebecor (TSE:QBR.B) on 8/9/2013

MarketBeat Community Rating for Ci Capital

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  24,031 (Vote Outperform)
Underperform Votes:  20,769 (Vote Underperform)
Total Votes:  44,800
MarketBeat's community ratings are surveys of what our community members think about Ci Capital and other research firms. Vote "Outperform" if you believe Ci Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Ci Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools